Form 8-K - Current report:
SEC Accession No. 0001062993-26-002371
Filing Date
2026-05-07
Accepted
2026-05-06 18:12:55
Documents
15
Period of Report
2026-05-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 16598
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 150634
8 GRAPHIC exhibit99-1x001.jpg GRAPHIC 7007
  Complete submission text file 0001062993-26-002371.txt   401452

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inm-20260506.xsd EX-101.SCH 4681
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inm-20260506_cal.xml EX-101.CAL 697
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inm-20260506_def.xml EX-101.DEF 22557
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inm-20260506_lab.xml EX-101.LAB 47254
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inm-20260506_pre.xml EX-101.PRE 25246
19 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3270
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 26950081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)